Alterome Therapeutics

Acquired

Home - Alterome

San Diego, United States · Founded 2021 · $231.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$231.0M
Last Round
$132.0M Series BApr 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021 and headquartered in San Diego, California. The company is developing first-in-class, alteration-specific therapies targeting AKT E17K- and KRAS-driven cancers, aiming to deliver safer and more precise treatments. Alterome has raised over million to advance its pipeline of novel oncology candidates.

Summary

Alterome Therapeutics is a Biotech company based in San Diego, United States, founded in 2021. It has raised $231.0M in total across 3 rounds, most recently a $132.0M Series B round in Apr 2024.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2024
$132.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alterome Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alterome-therapeutics"><img src="https://indexed.vc/api/badge/company/alterome-therapeutics" alt="Alterome Therapeutics on Indexed.vc" width="260" height="76" /></a>